Genetically determined subdivision of human populations with respect to the risk of breast cancer in women

Doklady Biological Sciences

Volumn 406, Issue 1-6, 2006, Pages 66-69

  Tarasov, V A ^a   Aslanyan, M M ^b   Tsyrendorzhiyeva, E S ^a   Litvinov, S S ^b   Gar'kavtseva, R F ^c   Altukhov, Yu P ^a  

^a VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BARD1 PROTEIN, HUMAN; BRCA1 PROTEIN; BRCA2 PROTEIN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA BINDING PROTEIN; G T MISMATCH BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; NBS1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN P53; RAD51 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST TUMOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; POINT MUTATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AMINO ACID SUBSTITUTION; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NUCLEAR PROTEINS; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RAD51 RECOMBINASE; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 33645355906     PISSN: 00124966     EISSN: 16083105     Source Type: Journal    
DOI: 10.1134/S0012496606010182     Document Type: Article

References (15)

1. Miki, Y., Swensen, J., Shattuck-Eidens, D., et al., Science, 1994, vol. 266, pp. 66-71.
2. Easton, D.F., Steele, L., Fields, P., et al., Am. J. Hum. Genet., 1997, vol. 61, pp. 120-128.
3. Ford, D., Easton, D.F., Stratton, M., et al., Am. J. Hum. Genet., 1998, vol. 62, pp. 676-689.
4. Levy-Lahad, E., Lahad, A., Eisenberg, S., et al., Proc. Nat. Acad. Sci. USA, 2001, vol. 98, pp. 3232-3236.
5. Fodor, F.H., Weston, A., Bleiweiss, I.J., et al., Am. J. Hum. Genet., 1998, vol. 63, pp. 45-51.
6. Arason, A., Barkardottir, R.B., and Egilsson, V., Am. J. Hum. Genet., 1993, vol. 52, pp. 711-717.
7. Welcsh, P.L. and King, M.-C., Hum. Mol. Genet., 2001, vol. 10, pp. 705-713.
8. Tarasov, V.A., Aslanyan, M.M., Tsyrendorzhieva, E.S., et al., Dokl. Akad. Nauk, 2004, vol. 398, no. 2, pp. 282-285
9. [Dokl. Biol. Sci. (Engl. Transl.), vol. 398, no. 2, pp. 391-394] .
10. Wang, Y., Cortez, D., Yazdi, P., et al., Genes Dev., 2000, vol. 14, pp. 927-939.
11. Welsh, P.L. and Owens, K.N., TIG, 2000, vol. 16, pp. 69-74.
12. Ford, D., Easton, D.F., Bishop, D.T., et al., Breast Cancer Linkage Consortium. Lancet, 1994, vol. 19, pp. 692-695.
13. Tarasov, V.A., Aslanyan, M.M., Tsyrendorzhieva, E.S., et al., Genetika, 2005, vol. 41, no. 8, pp. 1115-1124.
14. El-Deiry, W.S., Tokino, T., Velculescu, V.E., et al., Cell, 1993, vol. 75, pp. 817-825.
15. Whitehouse, C.J., Taylor, R.M., Thistlethwaite, A., et al., Cell, 2001, vol. 104, pp. 107-117.